FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns a pharmaceutical composition for parenteral drop introduction intended for treating obesity.
EFFECT: well-chosen, balanced qualitative and quantitative composition provides creation of a dosage form suitable for effective body weight index reduction in a short period of time.
1 cl, 4 ex
Authors
Dates
2020-05-21—Published
2019-11-11—Filed